BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17683400)

  • 1. Modeling the norketamine metabolite in children and the implications for analgesia.
    Herd DW; Anderson BJ; Holford NH
    Paediatr Anaesth; 2007 Sep; 17(9):831-40. PubMed ID: 17683400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.
    Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S
    Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department.
    Herd D; Anderson BJ
    Paediatr Anaesth; 2007 Jul; 17(7):622-9. PubMed ID: 17564643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ketamine and its metabolite norketamine administered at a sub-anesthetic dose together with xylazine to calves prior to castration.
    Gehring R; Coetzee JF; Tarus-Sang J; Apley MD
    J Vet Pharmacol Ther; 2009 Apr; 32(2):124-8. PubMed ID: 19290941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an optimal sampling schedule for children receiving ketamine for short-term procedural sedation and analgesia.
    Sherwin CM; Stockmann C; Grimsrud K; Herd DW; Anderson BJ; Spigarelli MG
    Paediatr Anaesth; 2015 Feb; 25(2):211-6. PubMed ID: 25212712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.
    Anderson BJ; Pons G; Autret-Leca E; Allegaert K; Boccard E
    Paediatr Anaesth; 2005 Apr; 15(4):282-92. PubMed ID: 15787918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
    Sigtermans M; Dahan A; Mooren R; Bauer M; Kest B; Sarton E; Olofsen E
    Anesthesiology; 2009 Oct; 111(4):892-903. PubMed ID: 19741495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of S-ketamine during prolonged sedation at the pediatric intensive care unit.
    Flint RB; Brouwer CNM; Kränzlin ASC; Lie-A-Huen L; Bos AP; Mathôt RAA
    Paediatr Anaesth; 2017 Nov; 27(11):1098-1107. PubMed ID: 29030928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ketamine and its metabolite, norketamine, after intravenous administration of a bolus of ketamine to isoflurane-anesthetized dogs.
    Pypendop BH; Ilkiw JE
    Am J Vet Res; 2005 Dec; 66(12):2034-8. PubMed ID: 16379643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine.
    Hartvig P; Larsson E; Joachimsson PO
    J Cardiothorac Vasc Anesth; 1993 Apr; 7(2):148-53. PubMed ID: 8477017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis.
    Kamp J; Jonkman K; van Velzen M; Aarts L; Niesters M; Dahan A; Olofsen E
    Br J Anaesth; 2020 Nov; 125(5):750-761. PubMed ID: 32838982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing.
    Fanta S; Kinnunen M; Backman JT; Kalso E
    Eur J Clin Pharmacol; 2015 Apr; 71(4):441-7. PubMed ID: 25724645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the pharmacodynamics of ketamine in children.
    Herd DW; Anderson BJ; Keene NA; Holford NH
    Paediatr Anaesth; 2008 Jan; 18(1):36-42. PubMed ID: 18095964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rifampicin on S-ketamine and S-norketamine plasma concentrations in healthy volunteers after intravenous S-ketamine administration.
    Noppers I; Olofsen E; Niesters M; Aarts L; Mooren R; Dahan A; Kharasch E; Sarton E
    Anesthesiology; 2011 Jun; 114(6):1435-45. PubMed ID: 21508826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexmedetomidine disposition in children: a population analysis.
    Potts AL; Warman GR; Anderson BJ
    Paediatr Anaesth; 2008 Aug; 18(8):722-30. PubMed ID: 18613931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine anesthesia in children--exploring infusion regimens.
    Dallimore D; Anderson BJ; Short TG; Herd DW
    Paediatr Anaesth; 2008 Aug; 18(8):708-14. PubMed ID: 18613930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of ketamine and norketamine in hair after a single dose.
    Xiang P; Sun Q; Shen B; Shen M
    Int J Legal Med; 2011 Nov; 125(6):831-40. PubMed ID: 21153031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of ketamine in children with heart disease.
    Elkomy MH; Drover DR; Hammer GB; Galinkin JL; Ramamoorthy C
    Int J Pharm; 2015 Jan; 478(1):223-231. PubMed ID: 25448584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.